Patents/Assignees

CLEXIO BIOSCIENCES Ltd.

20 patents in portfolio

US12589083utility2026
Abuse-deterrent Dosage Forms Containing Esketamine
0 cites
US12478592utility2025
Dosage Regime with Esketamine for Treating Neuropsychiatric or Neurological Conditions
0 cites
US12364672utility2025
Esketamine for Use in Treating Major Depressive Disorder
0 cites
US12336970utility2025
Method of Treating Major Depressive Disorder
0 cites
US12280022utility2025
Method of Treating Major Depressive Disorder
0 cites
US12268658utility2025
Dosage Regime with Esketamine for Treating Major Depressive Disorder
0 cites
US12239634utility2025
Methods of Treating Pruritus
0 cites
US12076300utility2024
Dosage Regime with Esketamine for Treating Major Depressive Disorder
0 cites
US12036189utility2024
Method of Treating Major Depressive Disorder
0 cites
US12016832utility2024
Method of Treating Major Depressive Disorder
0 cites
US11992468utility2024
Abuse-deterrent Dosage Forms Containing Esketamine
0 cites
US11964120utility2024
Long Acting Gastric Residence System
0 cites
US11957645utility2024
Method of Treating Major Depressive Disorder
0 cites
US11903928utility2024
Methods of Treating Pruritus
0 cites
US11865088utility2024
Method of Treating Major Depressive Disorder
0 cites
US11844796utility2023
Immediate Release Abuse-deterrent Granulated Dosage Forms
0 cites
US11730702utility2023
Immediate Release Abuse-deterrent Granulated Dosage Forms
0 cites
US11648198utility2023
Expandable Gastroretentive Dosage Form
0 cites
US11577061utility2023
Gastric Residence System
0 cites
US11547839utility2023
Long Acting Gastric Residence System
0 cites